Skip to main content

Advertisement

Log in

Environmental monitoring by surface sampling for cytotoxics: a review

Environmental Monitoring and Assessment Aims and scope Submit manuscript

Abstract

Environmental monitoring is usually conducted by surface sampling to detect and quantify the presence of cytotoxic drugs after their reconstitution and administration. This technique reveals the origins of residual contamination and is an important component in order to protect healthcare workers from the potential risk of occupational exposure. The aim of this work is to compare various techniques and results of surface sampling for cytotoxics. For each technique, sample processing methods and their analysis were compared from literature data. Sampling is often performed by the wiping technique. After treatment, various single or multicompound technical analyses are used, in particular liquid or gas chromatography involving different detection methods: ultraviolet, mass spectrometry, plasma torch, and voltammetry. Some methods are validated to ensure reliability. Despite published guidelines and the use of isolator technology for the preparation of cytotoxic drugs, workplace contamination persists, leading to chemotherapeutic agents’ exposure of healthcare workers. Efforts need to be maintained with particular emphasis on harmonization and on determining alert level for cytotoxic contamination.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • American Society of Health-System Pharmacists. (2006). ASHP guidelines on handling hazardous drugs. American Journal of Health-System Pharmacy, 63(12), 1172–1191.

    Article  Google Scholar 

  • ANSM: French National Agency of Medicine and Health Products Safety. (2007). Bonnes pratiques de preparation, chapitre 7: Préparations de médicaments contenant des substances dangereuses pour le personnel et l’environnement. Resource document. http://ansm.sante.fr/var/ansm_site/storage/original/application/a5d6ae4b3d5fdee013ca463462b7b296.pdf. Accessed 20 June 2016. [French].

  • Baumann, F., & Preiss, R. (2001). Cyclophosphamide and related anticancer drugs. BJournal of Chromatography B, Biomedical Sciences and Applications, 764(1–2), 173–192.

    Article  CAS  Google Scholar 

  • Brouwers, E. E., Huitema, A. D., Bakker, E. N., Douma, J. W., Schimmel, K. J., Van Weringh, G., et al. (2007). Monitoring of platinum surface contamination in seven Dutch hospital pharmacies using inductively coupled plasma mass spectrometry. International Archives of Occupational and Environmental Health, 80(8), 689–699.

    Article  CAS  Google Scholar 

  • Bussières, J. F., Tanguay, C., & Touzin, T. (2012). Environmental contamination with hazardous drugs in Quebec Hospitals. Canadian Journal of Hospital Pharmacy, 65(6), 428–435.

    Article  Google Scholar 

  • Castiglia, L., Miraglia, N., Pieri, M., Simonelli, A., Basilicata, P., Genovese, G., et al. (2008). Evaluation of occupational exposure to antiblastic drugs in an Italian hospital oncological department. Journal of Occupational Health, 50(1), 48–56.

    Article  CAS  Google Scholar 

  • Cavallo, D., Ursini, C. L., Perniconi, B., Di Francesco, A., Giglio, M., Rubino, F. M., et al. (2005). Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees. Mutation Research, 587(1–2), 45–51.

    Article  CAS  Google Scholar 

  • Connor, T. H. (2006). Hazardous anticancer drugs in health care: environmental exposure assessment. Annals of the New York Academy of Sciences, 1076, 615–623.

    Article  CAS  Google Scholar 

  • Connor, T. H., Anderson, R. W., Sessink, P. J., & Spivey, S. M. (2002). Effectiveness of a closed-system device in containing surface contamination with cyclophosphamide and ifosfamide in an i.V. Admixture area. American Journal of Health-System Pharmacy, 59(1), 68–72.

    CAS  Google Scholar 

  • Connor, T. H., Sessink, P. J., Harrison, B. R., Pretty, J. R., Peters, B. G., Alfaro, R. M., et al. (2005). Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: results of three studies. American Journal of Health-System Pharmacy, 62(5), 475–484.

    CAS  Google Scholar 

  • Connor, T. H., DeBord, D. G., Pretty, J. R., Oliver, M. S., Roth, T. S., Lees, P. S., et al. (2010). Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers. Journal of Occupational and Environmental Medicine, 52(10), 1019–1027.

    Article  Google Scholar 

  • Crauste-Manciet, S., Sessink, P. J., Ferrari, S., Jomier, J. Y., & Brossard, D. (2005). Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators. Annals of Occupational Hygiene, 49(7), 619–628.

    CAS  Google Scholar 

  • Donner, A. L. (1978). Possible risk of working with antineoplastic drugs in horizontal laminar flow hoods. American Journal of Hospital Pharmacy, 35(8), 900.

    CAS  Google Scholar 

  • Easty, A. C., Coakley, N., Cheng, R., Cividino, M., Savage, P., Tozer, R., et al. (2015). Safe handling of cytotoxics: guideline recommendations. Current Oncology, 22(1), e27–e37.

    Article  CAS  Google Scholar 

  • Ensslin, A. S., Pethran, A., Schierl, R., & Fruhmann, G. (1994). Urinary platinum in hospital personnel occupationally exposed to platinum-containing antineoplastic drugs. International Archives of Occupational and Environmental Health, 65(5), 339–342.

    Article  CAS  Google Scholar 

  • Favier, B., Gilles, L., Ardiet, C., & Latour, J. F. (2003). External contamination of vials containing cytotoxic agents supplied by pharmaceutical manufacturers. Journal of Oncology Pharmacy Practice, 9(1), 15–20.

    Article  CAS  Google Scholar 

  • Fleury-Souverain, S., Nussbaumer, S., Mattiuzzo, M., & Bonnabry, P. (2014). Determination of the external contamination and cross-contamination by cytotoxic drugs on the surfaces of vials available on the Swiss market. Journal of Oncology Pharmacy Practice, 20(2), 100–111.

    Article  Google Scholar 

  • Fransman, W., Huizer, D., Tuerk, J., & Kromhout, H. (2007a). Inhalation and dermal exposure to eight antineoplastic drugs in an industrial laundry facility. International Archives of Occupational and Environmental Health, 80(5), 396–403.

    Article  CAS  Google Scholar 

  • Fransman, W., Peelen, S., Hilhorst, S., Roeleveld, N., Heederik, D., & Kromhouts, H. (2007b). A pooled analysis to study trends in exposure to antineoplastic drugs among nurses. Annals of Occupational Hygiene, 51(3), 231–239.

    CAS  Google Scholar 

  • Gilbar, P. J. (2005). External contamination of cytotoxic drug vials. Journal of Pharmacy Practice and Research, 35(4), 264–265.

    Article  Google Scholar 

  • Gilles, L., Favier, B., Catillon, F., Dussart, C., Peyron, F., Simoens, X., et al. (2009). Optimisation des procédures de manipulation des chimiothérapies anticancéreuses : impact des contrôles de contamination environnementaux. Bulletin du Cancer, 96(9), 839–849 [French].

    CAS  Google Scholar 

  • Hedmer, M., & Wohlfart, G. (2012). Hygienic guidance values for wipe sampling of antineoplasic drugs in Swedish hospitals. Journal of Environmental Monitoring, 14(7), 1968–1675.

    Article  CAS  Google Scholar 

  • Hedmer, M., Jonsson, B. A., & Nygren, O. (2004). Development and validation of methods for environmental monitoring of cyclophosphamide in workplaces. Journal of Environmental Monitoring, 6(12), 979–984.

    Article  CAS  Google Scholar 

  • Huizing, M. T., Rosing, H., Koopman, F., Keung, A. C., Pinedo, H. M., & Beijnen, J. H. (1995). High-performance liquid chromatographic procedures for the quantitative determination of paclitaxel (Taxol) in human urine. Journal of chromatography. B, Biomedical sciences and applications, 664(2), 373–382.

    Article  CAS  Google Scholar 

  • International Agency for Research on Cancer (IARC). (2016). IARC monographs. Resource document. http://monographs.iarc.fr/ENG/Classification/. Accessed 20 June 2016.

  • International Society of Oncology Pharmacy Practitioners Standards Committee. (2007). ISOPP standards of practice. Safe handling of cytotoxics. Journal of Oncology Pharmacy Practice, 13, 1–81.

    Article  Google Scholar 

  • Juhascik, M. P., & Jenkins, A. J. (2009). Comparison of liquid/liquid and solid-phase extraction for alkaline drugs. Journal of Chromatographic Science, 47(7), 553–557.

    Article  CAS  Google Scholar 

  • Kiffmeyer, T. K., Tuerk, J., Hahn, M., Stuetzer, H., Hadtstein, C., Heinemann, A., et al. (2013). Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies—the MEWIP project. Annals of Occupational Hygiene, 57(4), 444–455.

    CAS  Google Scholar 

  • Konate, A., Poupon, J., Villa, A., Garnier, R., Hasni-Pichard, H., Mezzaroba, D., et al. (2011). Evaluation of environmental contamination by platinum and exposure risks for healthcare workers during a heated intraperitoneal perioperative chemotherapy (HIPEC) procedure. Journal of Surgical Oncology, 103(1), 6–9.

    Article  Google Scholar 

  • Kopp, B., Crauste-Manciet, S., Guibert, A., Mourier, W., Guerrault-Moro, M. N., Ferrari, S., et al. (2013). Environmental and biological monitoring of platinum-containing drugs in two hospital pharmacies using positive air pressure isolators. Annals of Occupational Hygiene, 57(3), 374–383.

    CAS  Google Scholar 

  • Kosjek, T., Perko, S., Žigon, D., & Heath, E. (2013). Fluorouracil in the environment: analysis, occurrence, degradation and transformation. Journal of Chromatography A, 1290, 62–72.

    Article  CAS  Google Scholar 

  • Krstey, S., Perunicić, B., & Vidacović, A. (2003). Work practice and some adverse health effects in nurses handling antineoplastic drugs. Medicina del Lavoro, 94(5), 432–439.

    Google Scholar 

  • Lee, S. G., Tkaczuk, M., Jankewicz, G., & Ambados, F. (2007). Surface contamination from cytotoxic chemotherapy following preparation and administration. Journal of Pharmacy Practice and Research, 37(4), 271–276.

    Article  Google Scholar 

  • Mason, H. J., Blair, S., Sams, C., Jones, K., Garfitt, S. J., Cuschieri, M. J., et al. (2005). Exposure to antineoplastic drugs in two UK hospital pharmacy units. Annals of Occupational Hygiene, 49(7), 603–610.

    CAS  Google Scholar 

  • McDevitt, J. J., Lees, P. S., & McDiarmid, M. A. (1993). Exposure of hospital pharmacists and nurses to antineoplastic agents. Journal of Occupational Medicine, 35(1), 57–60.

    CAS  Google Scholar 

  • McDiarmid, M. A., Rogers, B., & Oliver, M. S. (2014). Chromosomal effects of non-alkylating drug exposure in oncology personnel. Environmental and Molecular Mutagenesis, 55(4), 369–374.

    Article  CAS  Google Scholar 

  • Meijster, T., Fransman, W., Veldhof, R., & Kromhout, H. (2006). Exposure to antineoplastic drugs outside the hospital environment. Annals of Occupational Hygiene, 50(7), 657–664.

    CAS  Google Scholar 

  • Micoli, G., Turci, R., Arpellini, M., & Minoia, C. (2001). Determination of 5-fluorouracil in environmental samples by solid-phase extraction and high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography B, Biomedical Sciences and Applications, 750(1), 25–32.

    Article  CAS  Google Scholar 

  • Minoia, C., Turci, R., Sottani, C., Schiavi, A., Perbellini, L., Angeleri, S., et al. (1998). Application of high-performance liquid-chromatography tandem mass-spectrometry in the environmental and biological monitoring of health-care personnel occupationally exposed to cyclophosphamide and ifosfamide. Rapid Communications in Mass Spectrometry, 12(20), 1485–1493.

    Article  CAS  Google Scholar 

  • Naito, T., Osawa, T., Suzuki, N., Goto, T., Takada, A., Nakamichi, H., et al. (2012). Comparison of contamination levels on the exterior surfaces of vials containing platinum anticancer drugs in Japan. Biological and Pharmaceutical Bulletin, 35(11), 2043–2049.

    Article  CAS  Google Scholar 

  • Ng, L. M., & Jaffe, N. (1970). Possible hazards of handling antineoplastic drugs. Pediatrics, 46(4), 648–649.

    CAS  Google Scholar 

  • National Institute for Occupational Safety and Health (NIOSH). (2004). NIOSH alert: preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings. No. 2004-165. Atlanta (GA): Department of Health and Human Services (US), Centers for Disease Control and Prevention. Ressource document. www.cdc.gov/niosh/docs/2004-165/. Accessed 20 June 2016.

  • National Institute for Occupational Safety and Health (NIOSH). (2014). NIOSH list of antineoplastic drugs and other hazardous drugs in healthcare settings. No. 2014-138. Atlanta (GA): Department of Health and Human Services (US), Centers for Disease Control and Prevention. Resource document. www.cdc.gov/niosh/docs/2014-138/. Accessed 20 June 2016.

  • Nussbaumer, S., Fleury-Souverain, S., Antinori, P., Sadeghipour, F., Hochstrasser, D. F., Bonnabry, P., et al. (2010). Simultaneous quantification of ten cytotoxic drugs by a validated LC–ESI–MS/MS method. Analytical and Bioanalytical Chemistry, 398(7–8), 3033–3042.

    Article  CAS  Google Scholar 

  • Nussbaumer, S., Geiser, L., Sadeghipour, F., Hochstrasser, D., Bonnabry, P., Veuthey, J. L., et al. (2012). Wipe sampling procedure coupled to LC-MS/MS analysis for the simultaneous determination of 10 cytotoxic drugs on different surfaces. Analytical and Bioanalytical Chemistry, 402(8), 2499–2509.

    Article  CAS  Google Scholar 

  • Nygren, O., Gustavsson, B., Strom, L., & Friberg, A. (2002). Cisplatin contamination observed on the outside of drug vials. Annals of Occupational Hygiene, 46(6), 555–557.

    CAS  Google Scholar 

  • Occupational Safety and Health Administration (OSHA), United States Department of Labor. (1999). Controlling occupational exposure to hazardous drugs. OSHA technical manual, section VI, chapter 2. Resource document. https://www.osha.gov/dts/osta/otm/otm_vi/otm_vi_2.html. Accessed 20 June 2016.

  • Pethran, A., Schierl, R., Hauff, K., Grimm, C. H., Boos, K. S., & Nowak, D. (2003). Uptake of antineoplastic agents in pharmacy and hospital personnel. Part I: monitoring of urinary concentrations. International Archives of Occupational and Environmental Health, 76, 5–10.

    CAS  Google Scholar 

  • Randolph, S. A. (2012). (NIOSH) hazardous drugs in health care settings—recognition and control. Workplace Health and Safety, 60(9), 412.

    Google Scholar 

  • Rombaldi, F., Cassini, C., Salvador, M., Saffi, J., & Erdtmann, B. (2009). Occupational risk assessment of genotoxicity and oxidative stress in workers handling anti-neoplastic drugs during a working week. Mutagenesis, 24(2), 143–148.

    Article  CAS  Google Scholar 

  • Sabatini, L., Barbieri, A., Tosi, M., & Violante, F. S. (2005). A new high-performance liquid chromatographic/electrospray ionization tandem mass spectrometric method for the simultaneous determination of cyclophosphamide, methotrexate and 5-fluorouracil as markers of surface contamination for occupational exposure monitoring. Journal of Mass Spectrometry, 40(5), 669–674.

    Article  CAS  Google Scholar 

  • Schierl, R., Böhlandt, A., & Nowak, D. (2009). Guidance values for surfaces monitoring of antineoplasic drugs in German pharmacies. Annals of Occupational Hygiene, 53(7), 703–711.

    CAS  Google Scholar 

  • Schierl, R., Herwig, A., Pfaller, A., Groebmair, S., & Fischer, E. (2010). Surface contamination of antineoplastic drug vials: comparison of unprotected and protected vials. American Journal of Health-System Pharmacy, 67(6), 428–429.

    Article  Google Scholar 

  • Schierl, R., Masini, C., Groeneveld, S., Fischer, E., Böhlandt, A., Rosini, V., et al. (2016). Environmental contamination by cyclophosphamide preparation: comparison of conventional manual production in biological safety cabinet and robot-assisted production by APOTECAchemo. Journal of Oncology Pharmacy Practice, 22(1), 37–45.

    Article  CAS  Google Scholar 

  • Schmaus, G., Schierl, R., & Funck, S. (2002). Monitoring surface contamination by antineoplastic drugs using gas chromatography-mass spectrometry and voltammetry. American Journal of Health-System Pharmacy, 59(10), 956–961.

    CAS  Google Scholar 

  • Schreiber, C., Radon, K., Pethran, A., Schierl, R., Hauff, K., & Grimm, C. H. (2003). Uptake of antineoplastic agents in pharmacy personnel. Part II study of work-related risk factors. International Archives of Occupational and Environmental Health, 76(1), 11–16.

    CAS  Google Scholar 

  • Sessink, P. J., Boer, K. A., Scheefhals, A. P., Anzion, R. B., & Bos, R. P. (1992). Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers. International Archives of Occupational and Environmental Health, 64(2), 105–112.

    Article  CAS  Google Scholar 

  • Sessink, P. J., Connor, T. H., Jorgenson, J. A., & Tyler, T. G. (2011). Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device. Journal of Oncology Pharmacy Practice, 17(1), 39–48.

    Article  CAS  Google Scholar 

  • Sessink, P. J., Leclercq, G. M., Wouters, D. M., Halbardier, L., Hammad, C., & Kassoul, N. (2015). Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation. Journal of Oncology Pharmacy Practice, 21(2), 118–127.

    Article  CAS  Google Scholar 

  • Siderov, J., Kirsa, S., & McLauchlan, R. (2010). Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device. Journal of Oncology Pharmacy Practice, 16(1), 19–25.

    Article  CAS  Google Scholar 

  • Smith, J. P., Sammons, D. L., Pretty, J. R., Kurtz, K. S., Robertson, S. A., DeBord, D. G., et al. (2016). Detection of 5-fluorouracil surface contamination in near real time. Journal of Oncology Pharmacy Practice, 22(1), 60–67.

    Article  CAS  Google Scholar 

  • Sottani, C., Turci, R., Micoli, G., Fiorentino, M. L., & Minoia, C. (2000). Rapid and sensitive determination of paclitaxel (Taxol) in environmental samples by high- performance liquid chromatography tandem mass spectrometry. Rapid Communications in Mass Spectrometry, 14(10), 930–935.

    Article  CAS  Google Scholar 

  • Sottani, C., Turci, R., Schierl, R., Gaggeri, R., Barbieri, A., Violante, F. S., et al. (2007). Simultaneous determination of gemcitabine, taxol, cyclophosphamide and ifosfamide in wipe samples by high-performance liquid chromatography/tandem mass spectrometry: protocol of validation and uncertainty of measurement. Rapid Communications in Mass Spectrometry, 21(7), 1289–1296.

    Article  CAS  Google Scholar 

  • Sottani, C., Porro, B., Comelli, M., Imbriani, M., & Minoia, C. (2010). An analysis to study trends in occupational exposure to antineoplastic drugs among health care workers. Journal of Chromatography B, Biomedical Sciences and Applications, 878(27), 2593–2605.

    CAS  Google Scholar 

  • Stücker, I., Mandereau, L., & Hémon, D. (1993). Relationship between birthweight and occupational exposure to cytostatic drugs during or before pregnancy. Scandinavian Journal of Work, Environment & Health, 19(3), 148–153.

    Article  Google Scholar 

  • Tkaczuk, M., Lee, S. G., Jankewicz, G., & Ambados, F. (2010). Surface contamination of cytotoxic drug 5-fluorouracil (5-FU) and decontamination. Journal of Health, Safety and Environment, 26(2), 171–181.

    Google Scholar 

  • Touzin, K., Bussières, J. F., Langlois, E., Lefebvre, M., & Gallant, C. (2008). Cyclophosphamide contamination observed on the external surfaces of drug vials and the efficacy of cleaning on vial contamination. Annals of Occupational Hygiene, 52(8), 765–771.

    CAS  Google Scholar 

  • Tuerk, J., Kiffmeyer, T. K., Hadtstein, C., Heinemann, A., Hahn, M., Stuetzer, M., et al. (2011). Development and validation of an LC-MS/MS procedure for environmental monitoring of eight cytostatic drugs in pharmacies. International Journal of Environmental Analytical Chemistry, 91(12), 1178–1190.

    Article  CAS  Google Scholar 

  • Turci, R., & Minoia, C. (2006). Residual hazard assessment related to handling of antineoplastic drugs: safety system evolution and quality assurance of analytical measurement. Annals of the New York Academy of Sciences, 1076, 649–656.

    Article  CAS  Google Scholar 

  • Turci, R., Micoli, G., & Minoia, C. (2000). Determination of methotrexate in environmental samples by solid phase extraction and high performance liquid chromatography: ultraviolet or tandem mass spectrometry detection? Rapid Communications in Mass Spectrometry, 14(8), 685–691.

    Article  CAS  Google Scholar 

  • Turci, R., Sottani, C., Spagnoli, G., & Minoia, C. (2003). Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents: a review of analytical methods. Journal of Chromatography B, Biomedical Sciences and Applications, 789(2), 169–209.

    CAS  Google Scholar 

  • USP <797> (2004). Guidebook to pharmaceutical compounding—sterile preparations. In: The United States pharmacopeia [28th rev]—the national formulary (23rd edn) (pp 2461–2477). Rockville (MD): United States Pharmacopeial Convention.

  • Valanis, B. G., Vollmer, W. M., Labuhn, K. T., & Glass, A. G. (1993). Association of antineoplastic drug handling with acute adverse effects in pharmacy personnel. American Journal of Hospital Pharmacy, 50(3), 455–462.

    CAS  Google Scholar 

  • Valanis, B. G., Vollmer, W. M., & Steele, P. (1999). Occupational exposure to antineoplastic agents: self-reported miscarriages and stillbirths among nurses and pharmacists. Journal of Occupational and Environmental Medicine, 41(8), 632–638.

    Article  CAS  Google Scholar 

  • Wick, C., Slawson, M. H., Jorgenson, J. A., & Tyler, L. S. (2003). Using a closed-system protective device to reduce personnel exposure to antineoplastic agents. American Journal of Health-System Pharmacy, 60(22), 2314–2320.

    CAS  Google Scholar 

  • Working Committee on the Safe Handling of Hazardous Drugs. (2008). Prevention guide: safe handling of hazardous drugs. Montréal (QC): Association paritaire pour la santé et la sécurité au travail du secteur des affaires sociales. Ressource document. www.irsst.qc.ca/media/documents/PubIRSST/CG-002.pdf. Accessed 20 june 2016.

  • World Health Organization Regional Office for Europe (2002) Good practice in occupational health services: a contribution to workplace health. Resource document. http://www.euro.who.int/__data/assets/pdf_file/0007/115486/E77650.pdf. Accessed 11 November 2016.

  • Yuki, M., Sekine, S., Takase, K., Ishida, T., & Sessink, P. J. (2013). Exposure of family members to antineoplastic drugs via excreta of treated patients. Journal of Oncology Pharmacy Practice, 19(3), 208–217.

    Article  CAS  Google Scholar 

  • Yuki, M., Ishida, T., & Sekine, S. (2015). Secondary exposure of family members to cyclophosphamide after chemotherapy of outpatients with cancer: a pilot study. Oncology Nursing Forum, 42(6), 665–671.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Roche Manon.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marie, P., Christophe, C., Manon, R. et al. Environmental monitoring by surface sampling for cytotoxics: a review. Environ Monit Assess 189, 52 (2017). https://doi.org/10.1007/s10661-016-5762-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10661-016-5762-9

Keywords

Navigation